REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
REVELATION BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.29+2.80 (+577.76%)
Close on Oct 19, 2026
- Market cap
- $12.58M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Revelation Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 17, 2026 | Aug 19, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 1, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Feb 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 14, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 26, 2026 | Jan 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2026 | Jan 22, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 3, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 3, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 22, 2025 | Sep 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 25, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 23, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2025 | Jan 21, 2025 | SEC EDGAR |